Table 1. Participant Demographic Data in Pediatric BD Versus Typically Developing HC.
Group | PBD (M±SD) | HC (M±SD) | P value |
Age | 15.0±1.7 | 14.1±1.5 | 0.15* |
Full-Scale IQ | 97.9±10.62 | 101.3±5.58 | 0.282* |
Gender (Male/female) | 6/9 | 6/9 | 1.0# |
Race (yellow/other) | 15/0 | 15/0 | 1.0# |
Handness (left/right) | 0/15 | 0/15 | 1.0# |
YMRS | 36.5±4.1 | ||
MFQ | 10.3±4.3 | ||
Current Comorbid KSADS | |||
Diagnoses | |||
Obsessive-compulsive disorder | 2 (13.3%) | ||
Psychosis | 3 (20% ) | ||
Medications: Number and % | |||
of BD Participants | |||
Lithium | 6 (40%) | ||
Atypical antipsychotics | 11 (73.3%) | ||
Antidepressants | 2 (13.3%) | ||
Valproate | 8 (53.3%) | ||
Benzodiazepines | 1 (6%) | ||
Familial history | 1 (6%) |
Pediatric bipolar disorder (BD) (n = 15) vs. healthy control subjects (HC) (n = 15).
KSADS, Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version.
YMRS, Young Mania Rating Scale.
MFQ, Mood and Feelings Questionnaire.
Pearson χ2 two-tailed test.
Independent Sample T Test.